A new superbug dubbed as the “phantom menace” by scientists, is on the rise to malign the disease control scenario. The new strain is a Carbapenem-resistant Enterobacteriaceae (CRE) which has the potential to become widespread across the globe. Carbapenem-resistant Enterobacteriaceae (CRE) are bacteria that are often resistant to most classes of antibiotics and cause health care–associated infections with high mortality rates.
Among CRE, strains that carry plasmid-encoded carbapenemase enzymes that inactivate carbapenem antibiotics are of greatest public health concern because of their potential for rapid global dissemination, as evidenced by the increasing distribution of CRE that produce the Klebsiella pneumoniae carbapenemase and the New Delhi metallo-β-lactamase. Newly described resistance in Enterobacteriaceae, such as plasmid-mediated resistance to the one of the last-line…
